Ulcer Prevention II

NCT00629928 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
800
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca